An Open One-Step RT-qPCR for SARS-CoV-2 detection

Ariel Cerda,Maira Rivera,Grace Armijo,Catalina Ibarra-Henriquez,Javiera Reyes,Paula Blázquez-Sánchez,Javiera Avilés,Aníbal Arce,Aldo Seguel,Alexander J. Brown,Yesseny Vásquez,Marcelo Cortez-San Martín,Francisco A. Cubillos,Patricia García,Marcela Ferres,César A. Ramírez-Sarmiento,Fernán Federici,Rodrigo A. Gutiérrez
DOI: https://doi.org/10.1371/journal.pone.0297081
IF: 3.7
2024-01-25
PLoS ONE
Abstract:The COVID-19 pandemic has resulted in millions of deaths globally, and while several diagnostic systems were proposed, real-time reverse transcription polymerase chain reaction (RT-PCR) remains the gold standard. However, diagnostic reagents, including enzymes used in RT-PCR, are subject to centralized production models and intellectual property restrictions, which present a challenge for less developed countries. With the aim of generating a standardized One-Step open RT-qPCR protocol to detect SARS-CoV-2 RNA in clinical samples, we purified and tested recombinant enzymes and a non-proprietary buffer. The protocol utilized M-MLV RT and Taq DNA pol enzymes to perform a Taqman probe-based assay. Synthetic RNA samples were used to validate the One-Step RT-qPCR components, demonstrating sensitivity comparable to a commercial kit routinely employed in clinical settings for patient diagnosis. Further evaluation on 40 clinical samples (20 positive and 20 negative) confirmed its comparable diagnostic accuracy. This study represents a proof of concept for an open approach to developing diagnostic kits for viral infections and diseases, which could provide a cost-effective and accessible solution for less developed countries.
multidisciplinary sciences
What problem does this paper attempt to address?